| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.51 | 0.007 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |